Chengdu Kanghong Pharmaceutical Group News

Kanghong Pharmaceutical (002773): The steady growth of compassic focuses on the progress of innovative ophthalmology drugs

Huafu SecuritiesOct 27 12:51

Kanghong Pharmaceutical (002773): Comparecip has obtained overseas market entry qualifications and a rich matrix of ophthalmology products

Aug 31 00:00

Kanghong Pharmaceutical (002773): Combexipr HD and gene therapy, a leader in fundus vascular disease, drive the second curve

Aug 12 00:00

Kanghong Pharmaceutical (002773): Leading eye medicine, innovative ophthalmology and neurology drugs can be expected in the future

May 19 07:36

Kanghong Pharmaceutical (002773): Performance exceeded expectations and continued to release Compazip

Oct 29, 2023 00:00

Kanghong Pharmaceutical (002773): Compaxipro's high growth expects phased catalysis of the innovation pipeline

德邦證券Aug 28, 2023 00:00

Kanghong Pharmaceutical (002773): Performance is in line with expectations and growth is expected to resume throughout the year

中金公司Aug 31, 2021 00:00

Kanghong Pharmaceutical (002773): 2020 performance fell short of expectations. The epidemic affected the impact of the epidemic on Comperside's overseas phase 3 clinical trials

中金公司Apr 29, 2021 00:00

Kanghong Pharmaceutical (002773): Q4 performance exceeds expectations, and Compercept's overseas clinical progress is progressing smoothly

光大證券Mar 1, 2021 00:00

Kanghong Pharmaceutical (002773): better-than-expected R & D pipeline progress event

中信建投證券Mar 1, 2021 00:00

Kanghong Pharmaceutical (002773) 2020 performance KuaiBao comments: higher-than-expected performance and valuation improvement

浙商證券Feb 28, 2021 00:00

Kanghong Pharmaceutical (002773): revenue side meets expectations and profit side outperforms expectations Q4 outperforms expectations in a single quarter.

國盛證券Feb 28, 2021 00:00

Kanghong Pharmaceutical (002773): no more than 3.472 billion yuan will be raised by the proposed non-public offering of shares, mainly for Compaq overseas clinical use.

海通證券Dec 9, 2020 00:00

Kanghong Pharmaceutical (002773) 2020 fixed increase Plan comments: increase the overseas R & D volume and look forward to revealing the blindness

浙商證券Dec 6, 2020 00:00

Kanghong Pharmaceutical (002773): fixed additional funds to help Compaq International III Clinical Propulsion NAMD data are worth looking forward to

國盛證券Dec 6, 2020 00:00

Depth * company * convoy Pharmaceutical (002773): third quarter results gradually return to Compaq internationalization process continues to advance

中銀證券Nov 30, 2020 00:00

康弘药业(002773)：行业加速拐点初现 看好康柏西普进入放量长周期

浙商證券Nov 29, 2020 00:00

康弘药业(002773)2020年三季报点评：Q3业绩回暖 研发稳步推进

東方財富證券Nov 4, 2020 00:00

深度*公司*康弘药业(002773)：第三季度业绩逐步回复 康柏西普国际化进程持续推进

中銀證券Oct 28, 2020 00:00

Kanghong Pharmaceutical (002773): Q3 Compathep's sales grew rapidly, and globalization continued to advance

太平洋證券Oct 27, 2020 00:00